NeuroOne Medical Technologies Q4 Earnings Call Highlights
NeuroOne Medical Technologies (NASDAQ:NMTC) executives highlighted what they called a “record” fiscal 2025 and a company “inflection point” during the company’s fourth-quarter earnings call, pointing to sharp product revenue growth, improved margins, and multiple pipeline and regulatory milestones across its brain ablation, facial pain, lower back pain, and drug delivery initiatives. Fiscal 2025 financial results: […]
23 Dec 01:54 · The Markets Daily